Weight loss Xavier Becerra - Search News

The Washington Post on MSN · 2d

Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and Wegovy, medications costing the massive government health program billions of dollars a year.

Biden Adds Ozempic to Medicare Price Renegotiation Talks

Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations.

The Associated Press on MSN · 1d

Ozempic, Wegovy are among 15 drugs selected for Medicare’s price negotiations

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

Hosted on MSN · 2d

Ozempic could get cheaper as Medicare eyes drug price negotiations — and Novo Nordisk stock slips

The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of price negotiations, including the popular weight loss drugs Ozempic and Wegovy.

Scripps News on MSN2d

Xavier Becerra reflects on tenure as HHS secretary: 'We're leaving this country healthier and stronger'

Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and ...

1d

Becerra, With No Regrets, Defends Vaccine Mandates and Misinformation Fight

In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...

Hosted on MSN1d

Ozempic and Wegovy selected for next round of Medicare drug price negotiations

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

2d

US health secretary: price of targeted drugs should be lowered

U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to negotiate better prices for ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results